Athens Medical C.S.A. (IATR) — Capital Reinvestment Ratio

Latest as of June 2023: 1.64x

Athens Medical C.S.A. (IATR) has a Capital Reinvestment Ratio of 1.64x as of June 2023, meaning it reinvests 2% of its operating cash flow (€3.17 Million) in capital expenditures (€5.19 Million). See debt-free asset ratio of Athens Medical C.S.A. to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.64x
Capex / Operating Cash Flow

Operating Cash Flow

€3.17 Million
EUR

Capital Expenditures

€5.19 Million
EUR

Data as of

Jun 2023
Most recent filing

Athens Medical C.S.A. Capital Reinvestment Ratio (2014–2024)

This chart tracks Athens Medical C.S.A.'s Capital Reinvestment Ratio across 10 annual periods. Check IATR cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Athens Medical C.S.A. (2014–2024)

Year-by-year Capital Reinvestment Ratio for Athens Medical C.S.A. from 2014 to 2024. For live market cap and broader valuation context, see Athens Medical C.S.A. market cap and net worth.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 0.57x €46.44 Million €26.63 Million ▼ -33.0%
2023 0.86x €26.13 Million €22.35 Million ▼ -99.3%
2022 128.02x €124.00K €15.87 Million ▲ +17767.6%
2021 0.72x €15.75 Million €11.28 Million ▲ +307.0%
2020 0.18x €40.21 Million €7.08 Million ▼ -65.9%
2019 0.52x €31.50 Million €16.27 Million ▲ +29.9%
2018 0.40x €20.02 Million €7.96 Million ▲ +3.1%
2016 0.39x €9.78 Million €3.77 Million ▲ +147.2%
2015 0.16x €12.89 Million €2.01 Million ▼ -81.4%
2014 0.84x €3.58 Million €3.00 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow